Nika Pharmaceuticals Company Description

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.

It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV.

The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022.

Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Nika Pharmaceuticals, Inc.

Country	United States
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Dimitar Savov

Contact Details

Address: 2269 Merrimack Valley Avenue Henderson, Colorado 89044 United States
Phone	702 326 3615
Website	nikapharmaceuticals.com

Stock Details

Ticker Symbol	NIKA
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US46020A1060
SIC Code	2834

Key Executives

Name	Position
Dimitar Slavchev Savov	President, Chief Executive Officer, Chief Financial Officer and Director
Clifford Redekop	Secretary and Director